InnerDyne's Radial Dilation Technology Presented At American Urological Association Annual Meeting.Business Editors/Health and Medical Writers American Urological Association Annual Meeting SUNNYVALE, Calif.--(BW HealthWire)--May 4, 2000 InnerDyne, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on NM: IDYN) today announced that the Company's first product addressing the urology marketplace was reviewed at the 95th Annual Meeting of the American Urological Association ("AUA AUA American Urological Association, see there ") in Atlanta on May 3, 2000. The AUA conference marks the first time the Company has participated in a major medical meeting focused on the application of its proprietary radial dilation dilation /di·la·tion/ (di-la´shun) 1. the act of dilating or stretching. 2. dilatation. di·la·tion n. 1. technology to benefit urologic patients. The presentation covered a study conducted at the University of California The University of California has a combined student body of more than 191,000 students, over 1,340,000 living alumni, and a combined systemwide and campus endowment of just over $7.3 billion (8th largest in the United States). at San Francisco (UCSF UCSF University of California at San Francisco ) Medical Center, Department of Urology, under the direction of Marshall Stoller, M.D. The AUA presentation was made by Reza Goharderakhshan, M.D. of UCSF, who reviewed clinical and technical findings associated with the initial use of the product to facilitate the removal of kidney stones Kidney Stones Definition Kidney stones are solid accumulations of material that form in the tubal system of the kidney. Kidney stones cause problems when they block the flow of urine through or out of the kidney. . He concluded that the product "is a rapid, single step access system." He further noted that "intraluminal sleeve dilation eliminates guidewire dependence, limits renal displacement, and facilitates appropriate vector force for dilation." InnerDyne expects to formally launch the Company's urological access product in the U.S. market during the next few months. InnerDyne, Inc. designs, develops, manufactures and commercializes minimally invasive surgical access products incorporating its proprietary radial dilation technology. The Company also is pursuing applications for radial dilation in areas outside its primary market focus, and improvements in its proprietary biocompatible biocompatible /bio·com·pat·i·ble/ (-kom-pat´i-b'l) being harmonious with life; not having toxic or injurious effects on biological function. coatings technologies, which it intends to commercialize either internally or through strategic alliances. Except for the historical information contained herein, this news release contains forward-looking statements that are subject to risks and uncertainties, including those risks detailed from time to time in the Company's regulatory filings, including the annual report on Forms 10-K for the year ended December 31, 1999, and the Forms 10-Q for the quarters ended in 2000, as or to be filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion